BioCentury | Jul 8, 2006
Financial News

Paradigm raises L7 million

...million) in a series D round. Existing investors Avlar BioVentures; BioOne Capital; Merlin Biosciences; and Lloyds TSB Development Capital...
BioCentury | Dec 19, 2005
Strategy

Cyclacel funding history

...Technology 8/12/99 Venture (ND) $6.4 Brian Souter; Ann Gloag 6/14/01 Series C $46.9 Invesco; BankInvest; Lloyds TSB Development Capital...
BioCentury | Aug 6, 2001
Finance

Ebb & Flow

...will focus on seed and early stage investments in biotechnology and related companies. Investors include Lloyds TSB Development Capital...
BioCentury | Jul 30, 2001
Financial News

Avlar starts 75 million fund

...seed and early stage investments in biotechnology and related companies. Investors in the fund include Lloyds TSB Development Capital...
BioCentury | Jun 14, 2001
Financial News

Cyclacel raises 34 million

...series C private placement led by Invesco Private Capital. Other investors included BankInvest Asset Management; Lloyds TSB Development Capital...
BioCentury | Sep 11, 2000
Finance

What Europe needs to follow on

...drug delivery, medical device, medical services, diagnostics and biotech companies in the U.K. and Europe. Lloyds TSB Development Capital...
Items per page:
1 - 6 of 6
BioCentury | Jul 8, 2006
Financial News

Paradigm raises L7 million

...million) in a series D round. Existing investors Avlar BioVentures; BioOne Capital; Merlin Biosciences; and Lloyds TSB Development Capital...
BioCentury | Dec 19, 2005
Strategy

Cyclacel funding history

...Technology 8/12/99 Venture (ND) $6.4 Brian Souter; Ann Gloag 6/14/01 Series C $46.9 Invesco; BankInvest; Lloyds TSB Development Capital...
BioCentury | Aug 6, 2001
Finance

Ebb & Flow

...will focus on seed and early stage investments in biotechnology and related companies. Investors include Lloyds TSB Development Capital...
BioCentury | Jul 30, 2001
Financial News

Avlar starts 75 million fund

...seed and early stage investments in biotechnology and related companies. Investors in the fund include Lloyds TSB Development Capital...
BioCentury | Jun 14, 2001
Financial News

Cyclacel raises 34 million

...series C private placement led by Invesco Private Capital. Other investors included BankInvest Asset Management; Lloyds TSB Development Capital...
BioCentury | Sep 11, 2000
Finance

What Europe needs to follow on

...drug delivery, medical device, medical services, diagnostics and biotech companies in the U.K. and Europe. Lloyds TSB Development Capital...
Items per page:
1 - 6 of 6